720TiP Phase I/II study of ipilimumab plus nivolumab (IPI-NIVO) combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma
Authors:
- 1 September 2021
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 32, S724